Mikael Chéramy

GAD Treatment and Insulin Secretion in Recent-Onset Type 1 Diabetes

Johnny Ludvigsson, Maria Faresjö, Maria Hjorth et al. · New England Journal of Medicine · 2008 · 510 citations · Full text

Extended evaluation of the safety and efficacy of GAD treatment of children and adolescents with recent-onset type 1 diabetes: a randomised controlled trial

Johnny Ludvigsson, Martin Hjorth, Mikael Chéramy et al. · Diabetologia · 2010 · 77 citations · Full text

Extended Evaluation, Gad Treatment, Diabetes Management +5

GAD‐treatment of children and adolescents with recent‐onset type 1 diabetes preserves residual insulin secretion after 30 months

Johnny Ludvigsson, Mikael Chéramy, Stina Axelsson et al. · Diabetes/Metabolism Research and Reviews · 2013 · 41 citations

GAD-alum treatment in patients with type 1 diabetes and the subsequent effect on GADA IgG subclass distribution, GAD65 enzyme activity and humoral response

Mikael Chéramy, Camilla Skoglund, I. Johansson et al. · Clinical Immunology · 2010 · 40 citations · Full text

Type 1, Diabetes Management, Insulin Management +5

Long-Lasting Immune Responses 4 Years after GAD-Alum Treatment in Children with Type 1 Diabetes

Stina Axelsson, Mikael Chéramy, Maria Hjorth et al. · PLoS ONE · 2011 · 40 citations · Full text